The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25021326 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mihaela Laura Vică und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Universitaire de la Francophonie.
Abstract (Originalsprache)
In this study, we aimed to investigate whether specific HLA alleles found in patients from Romania and the Republic of Moldova were associated with the severity of COVID-19 infection and its associated mortality. We analyzed the HLA alleles at the -A, -B, -C, -DRB1, and -DQB1 loci in a cohort of 130 individuals with severe and extremely severe forms of COVID-19, including 44 individuals who died. We compared these findings to a control group consisting of individuals who had either not been diagnosed with COVID-19 or had experienced mild forms of the disease. Using multivariate logistic regression models, we discovered that the B*27 and B*50 alleles were associated with an increased susceptibility to developing a severe form of COVID-19. The A*33 and C*15 alleles showed potential for offering protection against the disease. Furthermore, we identified two protective alleles (A*03 and DQB1*02) against the development of extremely severe forms of COVID-19. By utilizing score statistics, we established a statistically significant association between haplotypes and disease severity (p = 0.021). In summary, this study provides evidence that HLA genotype plays a role in influencing the clinical outcome of COVID-19 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Biology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
- Legal Medicine Institute, 400006 Cluj-Napoca, Romania.
- Emergency Clinical County Hospital, 540136 Târgu Mureș, Romania.
- Department of Laboratory Medicine, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania.
- Center for Advanced Medical and Pharmaceutical Research, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania.
- Department of Family Medicine, "Nicolae Testemițanu" State University of Medicine and Pharmacy, MD-2004 Chișinău, Moldova.
ORCID-Profile: Mihaela Laura Vică, Minodora Dobreanu, Daniel Corneliu Leucuța
Förderung
- Agence Universitaire de la Francophonie
Zitieren
APA
Vică, M. L., Dobreanu, M., Curocichin, G., Matei, H. V., Bâlici, Ș., Vușcan, M. E., Chiorean, A. D., Nicula, G. Z., Pavel Mironescu, D. C., Leucuța, D. C., Teodoru, C. A., & Siserman, C. V. (2024). The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021326
Vancouver
Vică ML, Dobreanu M, Curocichin G, Matei HV, Bâlici Ș, Vușcan ME, et al. The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021326
BibTeX
@article{Vic2024,
author = {Vică, Mihaela Laura and Dobreanu, Minodora and Curocichin, Ghenadie and Matei, Horea Vladi and Bâlici, Ștefana and Vușcan, Mihaela Elvira and Chiorean, Alin Dan and Nicula, Gheorghe Zsolt and Pavel Mironescu, Daniela Cristina and Leucuța, Daniel Corneliu and Teodoru, Cosmin Adrian and Siserman, Costel Vasile},
title = {The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25021326}
}
EUVIMED